Nexalin Technology (NXL) EBT Margin (2021 - 2026)
Nexalin Technology (NXL) recorded quarterly EBT Margin of 14025.67% in Q1 2026, down 914.47% quarter-over-quarter from 1382.56% in Q4 2025, and down 918039.0% on a YoY basis from N/an in Q1 2025.
Nexalin Technology (NXL) EBT Margin (2021 - 2026) Analysis & Trends
Nexalin Technology's EBT Margin history runs 6 years deep, the most recent figure standing at 14025.67% for Q1 2026.
- In Q1 2026, EBT Margin fell 918039.0% year-over-year to 14025.67%; the TTM figure through Mar 2026 stood at 3022.94% (up 350236.0% YoY), while the FY2025 annual figure was 2725.42%, up 178619.0% from the prior year.
- EBT Margin was 14025.67% for Q1 2026 at Nexalin Technology, down from 1382.56% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 55.68% in Q3 2022 to a low of 14025.67% in Q1 2026.
- Historically, EBT Margin has averaged 4626.58% across 5 years, with a median of 2449.0% in 2023.
- The sharpest annual moves came in 2023 and 2025: EBT Margin plunged 947108 bps in 2023, then soared 904268 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 1907.96% in 2022, then sank by 99 bps to 3801.47% in 2023, then tumbled by 174 bps to 10425.24% in 2024, then jumped by 87 bps to 1382.56% in 2025, then sank by 914 bps to 14025.67% in 2026.
- The last three EBT Margin figures came in at 14025.67% (Q1 2026), 1382.56% (Q4 2025), and 12542.35% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Nexalin Technology | 7.82 Mn | 5.11 Mn | 13,133.00 | -14,025.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14,025.67% |
| Dec 31, 2025 | -1,382.56% |
| Sep 30, 2025 | -12,542.35% |
| Jun 30, 2025 | -2,239.74% |
| Mar 31, 2025 | -4,845.27% |
| Dec 31, 2024 | -10,425.24% |
| Sep 30, 2024 | -6,795.30% |
| Jun 30, 2024 | -4,780.93% |
| Mar 31, 2024 | -1,330.78% |
| Dec 31, 2023 | -3,801.47% |
| Sep 30, 2023 | -9,526.77% |
| Jun 30, 2023 | -2,314.12% |
| Mar 31, 2023 | -2,449.00% |
| Dec 31, 2022 | -1,907.96% |
| Sep 30, 2022 | -55.68% |
| Jun 30, 2022 | -107.44% |
| Mar 31, 2022 | -121.63% |
| Dec 31, 2021 | -2,483.14% |
| Sep 30, 2021 | -3,256.43% |